The Central Dogma

DNA is the score; proteins are the performance.

Suggested next → The Neuron & Action Potential · MIND

The brief

In 1957, four years after his work on the structure of DNA, Francis Crick proposed what he provocatively called the Central Dogma of molecular biology: DNA is transcribed into RNA, and RNA is translated into protein, and information does not flow back from protein to nucleic acid. The genetic code goes one way. Crick later admitted he had misused the word — he meant a grand, sweeping idea, but 'dogma' properly names something held without proof, the opposite of his intent. The name stuck anyway, and so did the framework: for the first time heredity had a direction and a mechanism rather than merely a pattern. The dogma turned out to be approximately true, with important exceptions, and remains the organizing skeleton of molecular biology nearly seventy years later.

The mechanism is one of the great miracles of biological evolution. DNA stores hereditary information in a double-helical sequence of four bases. RNA (specifically messenger RNA) is transcribed from DNA by RNA polymerase, carrying a single-stranded copy out of the nucleus. Ribosomes read the mRNA in three-letter codons (each specifying one amino acid) and assemble proteins — the working molecules of the cell — by linking amino acids in the specified order. The translation runs on a code: each of the 64 possible three-letter codons maps to one of twenty amino acids or to a stop signal, a dictionary that is redundant (several codons per amino acid) and very nearly universal across all life — a bacterium can read a human gene. Crick had predicted the missing piece before it was found: an adaptor molecule that recognizes a codon at one end and carries the matching amino acid at the other, since nothing about a nucleic-acid triplet physically resembles an amino acid. That adaptor turned out to be transfer RNA. His careful claim was always about information, not molecules — he allowed RNA→DNA and never ruled out the detours cells actually use; what he forbade was information flowing back out of protein into sequence, and that prohibition still stands. The exceptions to simple one-way flow are now well-characterized: retroviruses (including HIV) reverse-transcribe RNA back into DNA (David Baltimore and Howard Temin, 1970, Nobel 1975); prions propagate by protein-to-protein conformational change without nucleic-acid involvement; epigenetics allows heritable phenotypic changes through DNA methylation and histone modification rather than sequence change. The central dogma has been the framework underneath every twentieth- and twenty-first-century molecular biology breakthrough: gene cloning, polymerase chain reaction, recombinant DNA, the Human Genome Project, RNA interference, CRISPR-Cas9, mRNA vaccines, and the recent revolution in protein-structure prediction (AlphaFold).

Why nowmRNA vaccines (Pfizer-BioNTech, Moderna) — perhaps the most important medical technology of the 2020s — work by delivering RNA directly to cells and letting the cell's own protein-synthesis machinery produce the antigen. The technology was enabled by decades of central-dogma research and is now being applied to cancer immunotherapy, rare diseases, and additional infectious diseases. CRISPR edits DNA itself; gene therapy introduces new DNA into patients' cells; AlphaFold predicts the protein conformation that DNA sequences will produce. The dogma's edges keep softening as biology looks closer: most of the genome is transcribed into non-coding RNA that regulates rather than codes, and the RNA-world hypothesis holds that RNA both stored information and did chemistry before DNA and protein divided the labour. The dogma is no longer just a description of how cells work — it is also a programming language we are learning to write.